Intracoronary versus intravenous administration of tirofiban during percutaneous coronary intervention (PCI) in acute coronary syndrome (ACS) patients

Bibliographic Details
Main Authors:	S. Pradhan, P.K. Sahoo, S. Mallick
Format:	Article
Language:	English
Published:	Elsevier 2015-12-01
Series:	Indian Heart Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S0019483215005398

Efficacy and Safety of Intracoronary versus Intravenous Administration of Tirofiban during Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials.
by: Xiuying Tang, et al.
Published: (2015-01-01)

Intracoronary Versus Intravenous Administration of Eptifibatide During Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes
by: tooran makhdoumi
Published: (2020-10-01)

COMPARISON OF INTRACORONARY VERAPAMIL VS ADENOSINE FOR RESTORATION OF CORONARY BLOOD FLOW POST PERCUTANEOUS CORONARY INTERVENTION (PCI) IN PATIENTS WITH NO-REFLOW
by: Mohsin Saif, et al.
Published: (2020-12-01)

Antiplatelet medications in acute coronary syndromes and percutaneous coronary interventions: focus on tirofiban
by: T. A. Batyraliev, et al.
Published: (2008-12-01)

Effect of intracoronary sodium nitroprusside and tirofiban injection on myocardial injury in patients with no reflow in PCI
by: Xiang-Yang Xia
Published: (2018-04-01)

Effect of intracoronary injection of tirofiban combined with anisodamine on myocardial perfusion in patients with STEMI after PCI
by: Xiao-Gang Zhu, et al.
Published: (2016-10-01)

Effect of papaverine combined with tirofiban intracoronary injection on the degree of myocardial injury in patients with no reflow during PCI
by: De-Yin Zeng, et al.
Published: (2018-09-01)

PERCUTANEOUS CORONARY INTERVENTIONS: INTRAVASCULAR IMAGING AND ASSESSMENT OF INTRACORONARY HAEMODYNAMICS
by: Chernyak A. A., et al.
Published: (2020-12-01)

Intracoronary versus intravenous administration of abciximab in patients with acute coronary syndrome: a meta-analysis.
by: Jie-Ning Wang, et al.
Published: (2013-01-01)

High-dose bolus tirofiban versus low-dose bolus in patients with acute coronary syndrome undergoing percutaneous coronary intervention
by: Taner Ulus, et al.
Published: (2017-03-01)

Effect of preoperative small dose of tirofiban on PCI treatment in patients with acute coronary syndrome
by: Li Wang, et al.
Published: (2016-06-01)

Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical Trial
by: Dong Huang, et al.
Published: (2021-08-01)

EDITOR’S PICK: CONTEMPORARY USE OF INTRACORONARY IMAGING IN PERCUTANEOUS CORONARY INTERVENTION
by: Matthew E. Li Kam Wa, et al.
Published: (2018-10-01)

Comparison between Intracoronary Abciximab and Intravenous Eptifibatide Administration during Primary Percutaneous Coronary Intervention of Acute ST-Segment Elevation Myocardial Infarction
by: MohammadHasan Namazi, et al.
Published: (2015-10-01)

Efficacy and safety of quadruple therapy including tirofiban in the treatment of Chinese NSTE-ACS patients failing to receive timely percutaneous coronary intervention
by: Li L, et al.
Published: (2017-11-01)

Influence of Tirofiban maintenance duration on patients with acute myocardial infarction treated by percutaneous coronary intervention
by: Zhen-Guo Ji, et al.
Published: (2015-06-01)

Rate of Urgent Coronary Artery Bypass Grafting in Elective Percutaneous Coronary Intervention (PCI)
by: Seyed Amir Kassaei, et al.
Published: (2008-01-01)

Rate of Urgent Coronary Artery Bypass Grafting in Elective Percutaneous Coronary Intervention (PCI)
by: Yonos Nozari, et al.
Published: (2008-07-01)

Fractional Flow Reserve: Intracoronary versus intravenous adenosine induced maximal coronary hyperemia
by: P.S. Sandhu, et al.
Published: (2013-03-01)

Intracoronary Lithoplasty in Percutaneous Treatment of Challenging Calcified Coronary Lesions
by: Alfredo Marchese, MD, PhD, et al.
Published: (2020-09-01)

Assessment of Equity in Access to Percutaneous Coronary Intervention (PCI) Centres in Poland
by: Justyna Rój, et al.
Published: (2020-03-01)

Intracoronary Versus Intravenous Adenosine-Induced Maximal Coronary Hyperemia for Fractional Flow Reserve Measurements
by: Ahmed Khashaba, et al.
Published: (2014-02-01)

Intracoronary versus Intravenous Adenosine-Induced Maximal Coronary Hyperemia for Fractional Flow Reserve Measurements
by: Ahmed Khashaba, et al.
Published: (2014-01-01)

Comparison between the effect of intracoronary bolus of tirofiban versus eptifibatide as adjunctive antiplatelet therapy on the outcome of primary coronary intervention in patients with acute anterior ST segment elevation myocardial infarction
by: Tarek M. Zaki, et al.
Published: (2011-06-01)

Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration
by: Gu Youlan L, et al.
Published: (2009-09-01)

Triple versus dual antiplatelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI) – Our hospital experience
by: Karandeep Singh, et al.
Published: (2015-12-01)

IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)
by: Waseem Raja, et al.
Published: (2020-12-01)

Intracoronary Lithotripsy in Percutaneous Treatment of Calcific Left Main Coronary Stenoses
by: Carlos H. Salazar, MD, et al.
Published: (2019-06-01)

Comparison between Bolus Intracoronary versus Bolus Intravenous Injection Regimens of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Anterior ST-Segment Elevation Myocardial Infarction
by: Mohamed Hassan Nab, et al.
Published: (2019-03-01)

Acute Serious Thrombocytopenia Associated with Intracoronary Tirofiban Use for Primary Angioplasty
by: Mustafa Yurtdaş, et al.
Published: (2014-01-01)

Clinical efficacy and safety of tirofiban combined with conventional dual antiplatelet therapy in ACS patients undergoing PCI
by: Yong-zhe Guo, et al.
Published: (2021-08-01)

Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial
by: Wonjae Lee, et al.
Published: (2018-10-01)

Intracoronary administration of metabolic agents in the treatment of acute coronary syndrome
by: A. A. Spasski, et al.
Published: (2018-05-01)

Thrombolytic Therapy Up-regulates Inflammatory Mediators Compared to Percutaneous Coronary Intervention (PCI)
by: Alireza Garjani, et al.
Published: (2016-08-01)

Radial or femoral access in primary percutaneous coronary intervention (PCI): Does the choice matters?
by: Mahesh Kumar Batra, et al.
Published: (2020-05-01)

Marcadores inflamatórios intracoronarianos após intervenções coronarianas percutâneas Intracoronary inflammatory markers after percutaneous coronary interventions
by: Wilson Salgado Filho, et al.
Published: (2005-09-01)

Interventions in reducing anxiety among patients undergoing percutaneous coronary intervention (PCI): an integrated literature review
by: Effita Piscesiana, et al.
Published: (2021-08-01)

Study of saline optical coherence tomography–guided percutaneous coronary intervention (SOCT-PCI Study)
by: Nalin K. Mahesh, et al.
Published: (2020-07-01)

Bleeding Severity in Percutaneous Coronary Intervention (PCI) and Its Impact on Short-Term Clinical Outcomes
by: Shashank Murali, et al.
Published: (2020-05-01)

Exploring the health behaviour practices of elective ad-hoc percutaneous coronary intervention (PCI) patients
by: Throndson, Karen Lynn
Published: (2011)

Intracoronary versus intravenous administration of tirofiban during percutaneous coronary intervention (PCI) in acute coronary syndrome (ACS) patients

Similar Items

Similar Items